Formulation Development White Papers & Articles

  1. From Biomarker Data To Proof Of Mechanism 11/4/2026

    Biomarker values support mechanism only when the decision, analytical plan, and validation are designed as one chain, with expected direction of change and baseline noise defined before sampling.

  2. Expert Q&A: Navigating Complexity In Modern Small Molecule Development 11/3/2026

    Small molecules are growing larger, more potent, and more structurally complex while timelines compress. That combination reshapes scale-up, outsourcing relationships, and the criteria for choosing a manufacturing partner.

  3. A Connected Approach To OSD Development 11/2/2026

    See how an integrated OSD development strategy can identify risks early, strengthen process understanding and prepare products for scale-up, tech transfer and commercialization.

  4. Is Your API Right For A Soft Gel Capsule? 11/2/2026

    Soft gel delivery systems can enhance bioavailability, enable controlled release, support combination dosing, and handle potent compounds while improving stability and patient adherence.

  5. How A CDMO Overcomes Soft Gel Formulation Challenges 11/2/2026

    Softgel development demands careful control of shell properties, liquid fills, and stability. Overcoming formulation challenges improves drug delivery, bioavailability, and shelf life.

  6. Oral Solutions & Suspensions: The Art Of Pharmacy 11/2/2026

    Oral liquid formulations improve accessibility and dosing flexibility. Learn how developers overcome stability, taste-masking, and manufacturing challenges.

  7. 10 Qualities Your CDMO Should Have For An Oral Dose Tech Transfer 11/2/2026

    Choose a manufacturing partner that supports every development phase with regulatory expertise, supply chain resilience, and formulation know-how.

  8. 8 Must- Haves When Choosing A CDMO Partner For Drug Development 11/2/2026

    Complex programs raise the stakes of outsourcing. Eight criteria, each paired with questions to ask and signals to watch for, separate a true development partner from a vendor.

  9. A Guide To Bioavailability Enhancement 10/26/2026

    Many new drug candidates face oral bioavailability challenges. Particle engineering, lipid systems, and inclusion complexes can boost absorption, though patient variability remains a hurdle.

  10. A Strategic Guide For Challenging Early-Phase Molecules 10/26/2026

    Early formulation decisions for high-viscosity, unstable, and potent molecules impact scale-up, regulatory flexibility, and lifecycle value. Getting them right early helps avoid costly rework.